Literature DB >> 32355182

Compensation between Wnt-driven tumorigenesis and cellular responses to ribosome biogenesis inhibition in the murine intestinal epithelium.

Aurélien Raveux1,2, Aline Stedman1,3, Sabrina Coqueran1, Sandrine Vandormael-Pournin1, Nick Owens4, Béatrice Romagnolo5,6,7, Michel Cohen-Tannoudji8.   

Abstract

Ribosome biogenesis inhibition causes cell cycle arrest and apoptosis through the activation of tumor suppressor-dependent surveillance pathways. These responses are exacerbated in cancer cells, suggesting that targeting ribosome synthesis may be beneficial to patients. Here, we characterize the effect of the loss-of-function of Notchless (Nle), an essential actor of ribosome biogenesis, on the intestinal epithelium undergoing tumor initiation due to acute Apc loss-of-function. We show that ribosome biogenesis dysfunction strongly alleviates Wnt-driven tumor initiation by restoring cell cycle exit and differentiation in Apc-deficient progenitors. Conversely Wnt hyperactivation attenuates the cellular responses to surveillance pathways activation induced by ribosome biogenesis dysfunction, as proliferation was maintained at control-like levels in the stem cells and progenitors of double mutants. Thus, our data indicate that, while ribosome biogenesis inhibition efficiently reduces cancer cell proliferation in the intestinal epithelium, enhanced resistance of Apc-deficient stem and progenitor cells to ribosome biogenesis defects may be an important concern when using a therapeutic strategy targeting ribosome production for the treatment of Wnt-dependent tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32355182      PMCID: PMC7493937          DOI: 10.1038/s41418-020-0548-6

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  43 in total

1.  Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint.

Authors:  Stefano Fumagalli; Vasily V Ivanenkov; Teng Teng; George Thomas
Journal:  Genes Dev       Date:  2012-05-15       Impact factor: 11.361

2.  Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine.

Authors:  Pauline Andreu; Sabine Colnot; Cécile Godard; Sophie Gad; Philippe Chafey; Michiko Niwa-Kawakita; Pierre Laurent-Puig; Axel Kahn; Sylvie Robine; Christine Perret; Béatrice Romagnolo
Journal:  Development       Date:  2005-02-16       Impact factor: 6.868

3.  5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint.

Authors:  Giulio Donati; Suresh Peddigari; Carol A Mercer; George Thomas
Journal:  Cell Rep       Date:  2013-07-03       Impact factor: 9.423

4.  Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress.

Authors:  Sladana Bursać; Maja Cokarić Brdovčak; Martin Pfannkuchen; Ines Orsolić; Lior Golomb; Yan Zhu; Chen Katz; Lilyn Daftuar; Kristina Grabušić; Iva Vukelić; Vedrana Filić; Moshe Oren; Carol Prives; Siniša Volarevic
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-20       Impact factor: 11.205

5.  Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress.

Authors:  Kishore B Challagundla; Xiao-Xin Sun; Xiaoli Zhang; Tiffany DeVine; Qinghong Zhang; Rosalie C Sears; Mu-Shui Dai
Journal:  Mol Cell Biol       Date:  2011-08-01       Impact factor: 4.272

Review 6.  Does the ribosome translate cancer?

Authors:  Davide Ruggero; Pier Paolo Pandolfi
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

7.  A targeting modality for destruction of RNA polymerase I that possesses anticancer activity.

Authors:  Karita Peltonen; Laureen Colis; Hester Liu; Rishi Trivedi; Michael S Moubarek; Henna M Moore; Baoyan Bai; Michelle A Rudek; Charles J Bieberich; Marikki Laiho
Journal:  Cancer Cell       Date:  2014-01-13       Impact factor: 31.743

8.  Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53.

Authors:  Megan J Bywater; Gretchen Poortinga; Elaine Sanij; Nadine Hein; Abigail Peck; Carleen Cullinane; Meaghan Wall; Leonie Cluse; Denis Drygin; Kenna Anderes; Nanni Huser; Chris Proffitt; Joshua Bliesath; Mustapha Haddach; Michael K Schwaebe; David M Ryckman; William G Rice; Clemens Schmitt; Scott W Lowe; Ricky W Johnstone; Richard B Pearson; Grant A McArthur; Ross D Hannan
Journal:  Cancer Cell       Date:  2012-07-10       Impact factor: 31.743

9.  Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions.

Authors:  A Rose Brannon; Efsevia Vakiani; Brooke E Sylvester; Sasinya N Scott; Gregory McDermott; Ronak H Shah; Krishan Kania; Agnes Viale; Dayna M Oschwald; Vladimir Vacic; Anne-Katrin Emde; Andrea Cercek; Rona Yaeger; Nancy E Kemeny; Leonard B Saltz; Jinru Shia; Michael I D'Angelica; Martin R Weiser; David B Solit; Michael F Berger
Journal:  Genome Biol       Date:  2014-08-28       Impact factor: 13.583

10.  Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer.

Authors:  Dong-Wook Kim; Nan Wu; Young-Chul Kim; Pei Feng Cheng; Ryan Basom; Dongkyoon Kim; Colin T Dunn; Anastasia Y Lee; Keebeom Kim; Chang Sup Lee; Andrew Singh; Adi F Gazdar; Chris R Harris; Robert N Eisenman; Kwon-Sik Park; David MacPherson
Journal:  Genes Dev       Date:  2016-06-01       Impact factor: 11.361

View more
  3 in total

1.  Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancer.

Authors:  Shannon E Weeks; Sarah C Kammerud; Brandon J Metge; Heba A AlSheikh; David A Schneider; Dongquan Chen; Shi Wei; James A Mobley; Akinyemi I Ojesina; Lalita A Shevde; Rajeev S Samant
Journal:  Cell Death Dis       Date:  2021-03-04       Impact factor: 8.469

Review 2.  Intestinal Wnt in the transition from physiology to oncology.

Authors:  Julia Swoboda; Patrick Mittelsdorf; Yuan Chen; Ralf Weiskirchen; Johannes Stallhofer; Silke Schüle; Nikolaus Gassler
Journal:  World J Clin Oncol       Date:  2022-03-24

Review 3.  Ribosome Biogenesis Alterations in Colorectal Cancer.

Authors:  Sophie Nait Slimane; Virginie Marcel; Tanguy Fenouil; Frédéric Catez; Jean-Christophe Saurin; Philippe Bouvet; Jean-Jacques Diaz; Hichem C Mertani
Journal:  Cells       Date:  2020-10-27       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.